Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
(-)
News
(14)
Filter by content year
(-)
2022
(14)
Filter by form group
Filter by category
(-)
Events
(14)
(-)
Other
(14)
All
(10)
Financial
(4)
Collaborators
(2)
Filter by category
Search
News
Beschlüsse der Jahreshauptversammlung von BioNTech 2022
News
Voting Results from BioNTech’s Annual General Meeting 2022
News
BioNTech lädt zur ersten Ausgabe seiner „Innovation Series“ zur diversifizierten Pipeline und neuesten Technologie-Innovationen des Unternehmens ein
News
BioNTech to Host First Edition of Innovation Series on Diversified Pipeline, Latest Technology Innovations
News
BioNTech beginnt Bau der ersten Produktionsstätte für mRNA-basierte Impfstoffe in Afrika
News
BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
News
BioNTech veröffentlicht am 9. Mai 2022 Ergebnisse des ersten Quartals sowie Informationen zum operativen Fortschritt
News
BioNTech to Report First Quarter 2022 Financial Results and Operational Update on May 9, 2022
News
BioNTech stellt erste modulare mRNA-Produktionsanlage zur Unterstützung einer skalierbaren Impfstoffproduktion in Afrika vor
News
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
Pagination
Page 1
Next page
››